SGK
CLBT icon

Steigerwald Gordon & Koch’s Cellebrite CLBT Stock Holding History

Steigerwald Gordon & Koch’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39K Hold
95
– – ﹤0.01% 709
2026
Q1 		$1.31K Hold
95
– – ﹤0.01% 722
2025
Q4 		$1.71K Hold
95
– – ﹤0.01% 820
2025
Q3 		$1.76K Buy
+95
New +$1.49K ﹤0.01% 729

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Steigerwald Gordon & Koch's CLBT Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Cellebrite (CLBT) position steady in Q2 2026 at 95 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #709.

Steigerwald Gordon & Koch first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.76K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Steigerwald Gordon & Koch held 95 shares of Cellebrite worth $1.39K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #709 holding.
  • Steigerwald Gordon & Koch first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Cellebrite position peaked at $1.76K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.